We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

6 hedge funds and large institutions have $99.3K invested in PAVmed Inc. Series Z Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $97K → $99.3K (+$2.32K)

14% less funds holding

Funds holding: 7 → 6 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
+$139K
2
UBS Group
UBS Group
Switzerland
+$4.28K

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$20K
2
WAM
Warberg Asset Management
Illinois
-$17K
3
LCS
Levin Capital Strategies
New York
-$12.9K

PAVMZ Hedge Fund Activity: Q4 2022 in Review

6 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2022, worth a combined $99.3K — up 2.4% from $97K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PAVMZ and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Raymond James & Associates, opening a new position worth an estimated $139K. The largest seller was Wolverine Asset Management, cutting an estimated $20K.

  • 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2022, down from 7 in Q3 2022.
  • Funds reported $99.3K of PAVmed Inc. Series Z Warrant stock for Q4 2022, up 2.4% quarter-over-quarter.
  • 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q4 2022 and 2 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q4 2022 was Raymond James & Associates, an estimated $139K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q4 2022 was Wolverine Asset Management, an estimated $20K sold.

Based on aggregated 13F filings for Q4 2022.